Company intelligence / Profile preview

Beijing Fuyuan Pharmaceutical

Beijing, Beijing, Chinafshrcyy.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company is focused on both first-to-market generics and rapid imitation of clinically urgent drugs. It has established a product group across major therapeutic areas such as cardiovascular and diabetes, with ongoing investment into innovation capacity. The company aims to develop up to 100 new products over ten years. All manufacturing facilities are GMP-compliant per Chinese national standards.

Therapeutic areas: EndocrinologyDermatologyNeurologyGastroenterologyCardiovascularNephrologyWomen's Health
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

FY103

Unknown

Beyond the preview

Go deeper on Beijing Fuyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Fuyuan Pharmaceutical.

Explore the full profile